Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 83251-83300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05514158
To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)
PHASE1Recruiting
24 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05525858
KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
N/ARecruiting
1,000 participants
Started: Sep 28, 2022 · Completed: Mar 31, 2027
3 conditions3 sponsors32 locations
NCT05622682
Vaccine Immune Recovery After Leukemia
N/AEnrolling by invitation
400 participants
Started: Sep 28, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors6 locations
NCT05794217
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
N/ARecruiting
20,000 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05505994
The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
PHASE3Active, not recruiting
340 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2024
5 conditions1 sponsor1 location
NCT05491551
Alcohol-ROC-Training
NARecruiting
177 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT05391126
GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
NARecruiting
178 participants
Started: Sep 28, 2022 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT05483335
Assessing Burnout in Medical Students in Clerkship Years in United Arab Emirates
N/ARecruiting
132 participants
Started: Sep 28, 2022 · Completed: Jun 30, 2024
3 conditions1 sponsor1 location
NCT05555459
Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation
NARecruiting
125 participants
Started: Sep 28, 2022 · Completed: Nov 30, 2028
19 conditions1 sponsor1 location
NCT04088422
Cell Free DNA in Mature B-cell Lymphoma
N/ARecruiting
320 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05419934
EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial
NARecruiting
60 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05480930
Improving Nighttime Access to Care and Treatment; Part 4-Haiti
NARecruiting
7,124 participants
Started: Sep 27, 2022 · Completed: Sep 30, 2027
2 conditions2 sponsors1 location
NCT06148610
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
N/ARecruiting
170 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2024
3 conditions16 sponsors1 location
NCT05513365
Phase II Dutasteride in Combination With CAB vs CAB in SDC
PHASE2Recruiting
26 participants
Started: Sep 27, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05171075
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
PHASE3Recruiting
1,020 participants
Started: Sep 27, 2022 · Completed: Feb 28, 2027
3 conditions2 sponsors185 locations
NCT05241405
Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer
NARecruiting
354 participants
Started: Sep 27, 2022 · Completed: Sep 30, 2027
2 conditions3 sponsors10 locations
NCT05211180
Vida Sana y Completa Obesity and Food Insecurity Study
NAActive, not recruiting
412 participants
Started: Sep 27, 2022 · Completed: Oct 31, 2027
1 condition3 sponsors1 location
NCT05725200
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
PHASE2Recruiting
40 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2040
1 condition1 sponsor1 location
NCT05629494
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
PHASE4Recruiting
198 participants
Started: Sep 27, 2022 · Completed: Dec 1, 2026
3 conditions1 sponsor3 locations
NCT05503264
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
PHASE3Recruiting
152 participants
Started: Sep 27, 2022 · Completed: Dec 14, 2029
2 conditions2 sponsors87 locations
NCT05528952
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
PHASE2Recruiting
105 participants
Started: Sep 27, 2022 · Completed: Feb 27, 2030
1 condition3 sponsors14 locations
NCT05736848
A Retrospective Assessment of OviTex PRS (OviTex)
N/ARecruiting
200 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors11 locations
NCT05687565
Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV
NARecruiting
27 participants
Started: Sep 27, 2022 · Completed: Dec 21, 2025
1 condition1 sponsor1 location
NCT06239532
HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma
PHASE2Active, not recruiting
28 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05556044
Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction
PHASE3Recruiting
200 participants
Started: Sep 27, 2022 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT05611294
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
NAActive, not recruiting
42 participants
Started: Sep 27, 2022 · Completed: Jun 1, 2025
2 conditions2 sponsors1 location
NCT05532696
Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients
PHASE1/PHASE2Recruiting
61 participants
Started: Sep 27, 2022 · Completed: May 31, 2027
3 conditions1 sponsor5 locations
NCT05347095
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
PHASE3Active, not recruiting
288 participants
Started: Sep 27, 2022 · Completed: Mar 25, 2027
2 conditions1 sponsor153 locations
NCT05466149
Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion
PHASE2Active, not recruiting
100 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05682131
South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol
PHASE4Recruiting
210 participants
Started: Sep 27, 2022 · Completed: Sep 27, 2030
2 conditions14 sponsors1 location
NCT06190782
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
PHASE3Recruiting
354 participants
Started: Sep 27, 2022 · Completed: Sep 27, 2027
3 conditions1 sponsor1 location
NCT05526235
A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities
NARecruiting
150 participants
Started: Sep 27, 2022 · Completed: Sep 30, 2024
3 conditions3 sponsors1 location
NCT05082025
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
PHASE2Active, not recruiting
7 participants
Started: Sep 27, 2022 · Completed: Aug 29, 2025
2 conditions2 sponsors1 location
NCT05384691
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
PHASE2Recruiting
213 participants
Started: Sep 27, 2022 · Completed: Jul 31, 2027
2 conditions2 sponsors22 locations
NCT05330247
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
NAActive, not recruiting
100 participants
Started: Sep 27, 2022 · Completed: Jan 31, 2026
2 conditions7 sponsors1 location
NCT06063031
Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Condition
NAActive, not recruiting
146 participants
Started: Sep 26, 2022 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT05761392
APP-based Precise Management System of Chronic Intractable Pain
NARecruiting
120 participants
Started: Sep 26, 2022 · Completed: Sep 25, 2026
2 conditions1 sponsor1 location
NCT05991219
Screening and Secondary Prevention Rheumatic Heart Disease Study
N/ARecruiting
5,000 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05290051
Prospective Study to Assess Medical Performance of Optical Mapping and Long Read Sequencing in Detecting Numerical and Structural Chromosome Abnormalities
NARecruiting
400 participants
Started: Sep 26, 2022 · Completed: Jun 26, 2026
4 conditions10 sponsors1 location
NCT05418699
Real-life Data from Diabetic Patients on Closed-loop Pumps
N/AActive, not recruiting
439 participants
Started: Sep 26, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor5 locations
NCT05679583
Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer
PHASE2Recruiting
25 participants
Started: Sep 26, 2022 · Completed: Sep 25, 2026
1 condition1 sponsor1 location
NCT05102396
Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?
PHASE2Recruiting
17 participants
Started: Sep 26, 2022 · Completed: Aug 30, 2024
7 conditions2 sponsors1 location
NCT05572788
Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts
NARecruiting
600 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03536052
Ablation at Virtual-hEart pRedicted Targets for VT
NAActive, not recruiting
30 participants
Started: Sep 26, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05563012
Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma
PHASE2Recruiting
29 participants
Started: Sep 26, 2022 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT05397210
Post-market Clinical Follow-up (PMCF) Study of the Infinity-Lock Button System for Acromioclavicular Joint Stabilisation
N/ARecruiting
58 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor6 locations
NCT07147673
fNIRS Grasping Task in Infants
N/ARecruiting
100 participants
Started: Sep 26, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05292092
Essential Pro PMCF Study ( rEPIC04E )
N/ARecruiting
176 participants
Started: Sep 26, 2022 · Completed: Aug 30, 2025
2 conditions1 sponsor7 locations
NCT04777656
Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.
PHASE3Recruiting
120 participants
Started: Sep 26, 2022 · Completed: Nov 30, 2026
1 condition3 sponsors4 locations
NCT05483868
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
PHASE1Recruiting
55 participants
Started: Sep 26, 2022 · Completed: Apr 30, 2027
7 conditions1 sponsor10 locations